Clinical trial
Five-year Actively Controlled Clinical Trial in New Onset Juvenile…
NCT00323960 · Istituto Giannina Gaslini, Other · Completed
Key facts
| NCT number | NCT00323960 |
|---|---|
| Title | Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis |
| Official title | Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate |
| Acronym | PRINTOJDMTR |
| Lead sponsor | Istituto Giannina Gaslini, Other |
| Collaborators | Pediatric Rheumatology International Trials Organization |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Juvenile Dermatomyositis |
| Intervention type | Drug |
| Interventions | 3 MPDN pulse + PDN, 3 MPDN pulse + PDN + CSA, 3 MPDN pulse + PDN + MTX |
| Enrollment | 139 |
| Start date | May 31, 2006 |
| Primary completion | May 12, 2011 |
| Completion | Nov 29, 2015 |
| First posted | May 10, 2006 |
| Last update posted | Mar 28, 2023 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: